It has been reported that kaempferol could ameliorate the inhibitory effects of osteogenesis by activating JNK and p38 pathways in the glucocorticoid-induced and ovariectomy-induced osteoporosis model (Wong et al., 2019). The gene discussed is MAPK1; the disease is osteoporosis.